Gene · 23091
Papers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and biological significance of RNA N6-methyladenosine regulators in Alzheimer disease. | Medicine (Baltimore) | 2023 | 36800593 | PubTator, text mining | PubMed |
| Expression and significance of m6A-RNA-methylation in oral cancer and precancerous lesion. | Front Oncol | 2023 | 36793593 | PubTator, text mining | PubMed |
| METTL3 promotes SMSCs chondrogenic differentiation by targeting the MMP3, MMP13, and GATA3. | Regen Ther | 2023 | 36793308 | PubTator, text mining | PubMed |
| Thyroid cancer risk prediction model using m6A RNA methylation regulators: integrated bioinformatics analysis and histological validation. | Aging (Albany NY) | 2023 | 36791151 | PubTator, text mining | PubMed |
| N6-methyladenine regulator-mediated RNA methylation modification patterns in immune microenvironment regulation of osteoarthritis. | Front Genet | 2023 | 36777725 | PubTator, text mining | PubMed |
| Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC. | Sci Rep | 2023 | 36774418 | PubTator, text mining | PubMed |
| Current Insights into m6A RNA Methylation and Its Emerging Role in Plant Circadian Clock. | Plants (Basel) | 2023 | 36771711 | PubTator, text mining | PubMed |
| The Repertoire of RNA Modifications Orchestrates a Plethora of Cellular Responses. | Int J Mol Sci | 2023 | 36768716 | PubTator, text mining | PubMed |
| Integrated analysis of RNA methylation regulators crosstalk and immune infiltration for predictive and personalized therapy of diabetic nephropathy. | Hum Genomics | 2023 | 36765416 | PubTator, text mining | PubMed |
| Targeting and regulation of autophagy in hepatocellular carcinoma: revisiting the molecular interactions and mechanisms for new therapy approaches. | Cell Commun Signal | 2023 | 36759819 | PubTator, text mining | PubMed |
| Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation. | J Formos Med Assoc | 2023 | 36739231 | PubTator, text mining | PubMed |
| Identification of m6a-related signature genes in esophageal squamous cell carcinoma by machine learning method. | Front Genet | 2023 | 36733344 | PubTator, text mining | PubMed |
| HNRNPC suppresses tumor immune microenvironment by activating Treg cells promoting the progression of prostate cancer. | Cancer Sci | 2023 | 36718950 | PubTator, text mining | PubMed |
| Editorial: Biomolecular modifications in endocrine-related cancers. | Front Endocrinol (Lausanne) | 2023 | 36714076 | PubTator, text mining | PubMed |
| ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation. | Sci Rep | 2023 | 36709331 | PubTator, text mining | PubMed |
| Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma. | Eur J Med Res | 2023 | 36707911 | PubTator, text mining | PubMed |
| The potential role of m6A reader YTHDF1 as diagnostic biomarker and the signaling pathways in tumorigenesis and metastasis in pan-cancer. | Cell Death Discov | 2023 | 36707507 | PubTator, text mining | PubMed |
| METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey. | J Med Chem | 2023 | 36692498 | PubTator, text mining | PubMed |
| METTL3 knockdown promotes temozolomide sensitivity of glioma stem cells via decreasing MGMT and APNG mRNA stability. | Cell Death Discov | 2023 | 36683086 | PubTator, text mining | PubMed |
| N6-methylation of RNA-bound adenosine regulator HNRNPC promotes vascular endothelial dysfunction in type 2 diabetes mellitus by activating the PSEN1-mediated Notch pathway. | Diabetes Res Clin Pract | 2023 | 36681355 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23091/papers?page=20